Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC)

被引：0
|
作者：
R. Andrés
I. Pajares
J. Balmaña
G. Llort
T. Ramón y Cajal
I. Chirivella
E. Aguirre
L. Robles
E. Lastra
P. Pérez-Segura
N. Bosch
C. Yagüe
E. Lerma
J. Godino
M. D. Miramar
M. Moros
P. Astier
B. Saez
M. J. Vidal
A. Arcusa
S. Ramón y Cajal
M. T. Calvo
A. Tres
机构：
[1] Servicio de Oncología Médica,
[2] Hospital Clínico Lozano Blesa,undefined
[3] Hospital Vall d′Hebron de Barcelona,undefined
[4] Instituto Oncológic del Vallés,undefined
[5] Hospital de la Santa Creu y San Pau de Barcelona,undefined
[6] Hospital Clínico de Valencia,undefined
[7] Hospital Arnau de Vilanova de Lérida,undefined
[8] Hospital Universitario 12 de Octubre,undefined
[9] Hospital G. Yagüe de Burgos,undefined
[10] Hospital Clínico San Carlos de Madrid,undefined
[11] Aragon Health Science Institute,undefined
[12] Hospital Universitario Miguel Servet,undefined
[13] Centro de Salud San Pablo,undefined
[14] Hospital Valle Hebron,undefined
来源：
Clinical and Translational Oncology | 2014年 / 16卷
关键词：
Triple negative breast cancer; BRCA1; Hereditary breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：280 / 284
页数：4
相关论文
共 50 条
  • [31] A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2
    Kitahara, Miyuki
    Hozumi, Yasuo
    Machinaga, Mitsuki
    Hayashi, Yuka
    CASE REPORTS IN ONCOLOGY, 2021, 14 (03): : 1645 - 1651
  • [32] Natural History of Germline BRCA1 Mutated and BRCA Wild-type Triple-negative Breast Cancer
    Gardi, Nilesh
    Chaubal, Rohan
    Parab, Pallavi
    Pachakar, Sunil
    Kulkarni, Suyash
    Shet, Tanuja
    Joshi, Shalaka
    Kembhavi, Yogesh
    Chandrani, Pratik
    Quist, Jelmar
    Kowtal, Pradnya
    Grigoriadis, Anita
    Sarin, Rajiv
    Govindarajan, Raman
    Gupta, Sudeep
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (02): : 404 - 417
  • [33] BRCA1 deficiency is a recurrent event in early-onset triple-negative breast cancer: a comprehensive analysis of germline mutations and somatic promoter methylation
    Rafael Canfield Brianese
    Kivvi Duarte de Mello Nakamura
    Fernanda Gabriella dos Santos Ramos de Almeida
    Rodrigo Fernandes Ramalho
    Bruna Durães de Figueiredo Barros
    Elisa Napolitano e Ferreira
    Maria Nirvana da Cruz Formiga
    Victor Piana de Andrade
    Vladmir Claudio Cordeiro de Lima
    Dirce Maria Carraro
    Breast Cancer Research and Treatment, 2018, 167 : 803 - 814
  • [34] BRCA1 deficiency is a recurrent event in early-onset triple-negative breast cancer: a comprehensive analysis of germline mutations and somatic promoter methylation
    Brianese, Rafael Canfield
    de Mello Nakamura, Kivvi Duarte
    dos Santos Ramos de Almeida, Fernanda Gabriella
    Ramalho, Rodrigo Fernandes
    de Figueiredo Barros, Bruna Duraes
    Napolitano e Ferreira, Elisa
    da Cruz Formiga, Maria Nirvana
    de Andrade, Victor Piana
    Cordeiro de Lima, Vladmir Claudio
    Carraro, Dirce Maria
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (03) : 803 - 814
  • [35] Screening of BRCA1 and BRCA2 germline mutations in unselected triple-negative breast cancer patients: A series from north of Morocco
    Mansouri, Mohammed
    Derkaoui, Touria
    Bakkach, Joaira
    Loudiyi, Ali
    Ghailani Nourouti, Naima
    Barakat, Amina
    Martinez de Villarreal, Jaime
    Cortijo Bringas, Carlos
    Bennani Mechita, Mohcine
    PRECISION MEDICAL SCIENCES, 2020, 9 (01): : 43 - 48
  • [36] Effectiveness of microRNA expressions and PARP inhibitors for triple-negative breast cancer with BRCA1 mutations
    Sasaki, Akiko
    Tsunoda, Yuko
    Tsuji, Mayumi
    Udaka, Yuko
    Oyamada, Hideto
    Oguchi, Katsuji
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 170P - 170P
  • [37] Relative contributions of BRCA1 and BRCA2 mutations to “triple-negative” breast cancer in Ashkenazi Women
    E. Comen
    M. Davids
    T. Kirchhoff
    C. Hudis
    K. Offit
    M. Robson
    Breast Cancer Research and Treatment, 2011, 129 : 185 - 190
  • [38] Relative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi Women
    Comen, E.
    Davids, M.
    Kirchhoff, T.
    Hudis, C.
    Offit, K.
    Robson, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (01) : 185 - 190
  • [39] Prevalence of BRCA1 and BRCA2 Germline Mutations Among Pakistani Patients With Triple Negative Breast Cancer
    Rashid, M.
    Bajwa, S.
    Muhammad, N.
    Gull, S.
    Faisal, S.
    Amin, A.
    Loya, A.
    Hamann, U.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S254 - S255
  • [40] Association of BRCA1 promoter methylation in triple-negative breast cancer (TNBC) with resistance to standard anthracyline-based adjuvant chemotherapy
    Sharma, P.
    Kimler, B. F.
    Park, Y. A.
    Stecklein, S. R.
    Khan, Q. J.
    Petroff, B. K.
    Tawfik, O. W.
    Jensen, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345